Phase II Study of Docetaxel, Nedaplatin, and 5-Fluorouracil Combined Chemotherapy for Advanced Esophageal Cancer

被引：0
|
作者：
Tatsuya Miyazaki
Hitoshi Ojima
Minoru Fukuchi
Makoto Sakai
Makoto Sohda
Naritaka Tanaka
Shigemasa Suzuki
Keisuke Ieta
Kana Saito
Akihiko Sano
Takehiko Yokobori
Takanori Inose
Masanobu Nakajima
Hiroyuki Kato
Hiroyuki Kuwano
机构：
[1] Gunma University Graduate School,Department of General Surgical Science (Surgery 1)
[2] Gunma Prefectural Cancer Center,Department of Gastroenterological Surgery
[3] Gunma Chuo Hospital,Department of Surgery
[4] Isesaki Municipal Hospital,Department of Surgery
[5] Dokkyo Medical University,Department of Surgery I
来源：
Annals of Surgical Oncology | 2015年 / 22卷
关键词：
Docetaxel; Esophageal Cancer; Acute Kidney Injury; CDDP; Complete Response Rate;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3653 / 3658
页数：5
相关论文
共 50 条
  • [41] Phase I Dose-Escalation Study of Docetaxel, Cisplatin, and 5-Fluorouracil Combination Chemotherapy in Patients With Advanced Esophageal Carcinoma
    Satomura, Hitoshi
    Nakajima, Masanobu
    Sasaki, Kinro
    Yamaguchi, Satoru
    Domeki, Yasushi
    Takahashi, Masakazu
    Muroi, Hiroto
    Kubo, Tsukasa
    Kikuchi, Maiko
    Otomo, Haruka
    Ihara, Keisuke
    Kato, Hiroyuki
    INTERNATIONAL SURGERY, 2015, 100 (06) : 1153 - 1158
  • [42] A phase II study of infusional 5-fluorouracil and low-dose leucovorin with docetaxel for advanced gastric cancer
    Jeung, HC
    Rha, SY
    Kim, YT
    Noh, SH
    Roh, JK
    Chung, HC
    ONCOLOGY, 2006, 70 (01) : 63 - 70
  • [43] PHASE II STUDY OF OXALIPLATIN COMBINED WITH LEUCOVORIN AND 5-FLUOROURACIL AS FIRST-LINE CHEMOTHERAPY IN PATIENTS WITH ADVANCED GASTRIC CANCER
    Lim, J. Y.
    Cho, J. Y.
    Jeung, H.
    Kim, S. H.
    Lee, J.
    ANNALS OF ONCOLOGY, 2008, 19 : 183 - 184
  • [44] Long-term bresults of radiotherapy combined with nedaplatin and 5-fluorouracil for postoperative loco-regional recurrent esophageal cancer: update on a phase II study
    Keiichi Jingu
    Haruo Matsushita
    Ken Takeda
    Rei Umezawa
    Chiaki Takahashi
    Toshiyuki Sugawara
    Masaki Kubozono
    Keiko Abe
    Takaya Tanabe
    Yuko Shirata
    Takaya Yamamoto
    Youjirou Ishikawa
    Kenji Nemoto
    BMC Cancer, 12
  • [45] A phase II study of docetaxel, doxorubicin, and infusional 5-fluorouracil in the treatment of patients with locally advanced breast cancer
    Thatai, Lata Chandi
    Vishnubhotla, Priya
    Biernat, Laura
    Flaherty, Lawrence
    LoRusso, Patricia
    Simon, Michael
    Stephens, Deanna
    Vereeke, Kelly
    Abrams, Judith
    Bouwman, David
    Philip, Philip A.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2006, 29 (05): : 484 - 489
  • [46] Establishment of nedaplatin safety dose formula based on renal function for combination chemotherapy with nedaplatin and 5-fluorouracil in patients with esophageal cancer
    Takahashi, Masaya
    Takahashi, Katsuyuki
    Muguruma, Kazuya
    Ohira, Masaichi
    Nagayama, Katsuya
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2022, 27 (02) : 348 - 353
  • [47] Long-term results of radiotherapy combined with nedaplatin and 5-fluorouracil for postoperative loco-regional recurrent esophageal cancer: update on a phase II study
    Jingu, Keiichi
    Matsushita, Haruo
    Takeda, Ken
    Umezawa, Rei
    Takahashi, Chiaki
    Sugawara, Toshiyuki
    Kubozono, Masaki
    Abe, Keiko
    Tanabe, Takaya
    Shirata, Yuko
    Yamamoto, Takaya
    Ishikawa, Youjirou
    Nemoto, Kenji
    BMC CANCER, 2012, 12
  • [48] Phase I Study of Docetaxel, Cisplatin, and 5-Fluorouracil Chemoradiotherapy for Local or Metastatic Esophageal Cancer
    Iwasaki, Kenichi
    Osaka, Yoshiaki
    Tachibana, Shingo
    Suda, Takeshi
    Ota, Yoshihiro
    Hoshino, Sumito
    Tsuchida, Akihiko
    ANTICANCER RESEARCH, 2016, 36 (03) : 987 - 994
  • [49] Phase II study of paclitaxel, cisplatin, and 5-fluorouracil combination chemotherapy in patients with advanced gastric cancer
    Hwang, Junyl
    Cho, Sang-Hee
    Shim, Hyun Jeong
    Lee, Se-Ryeon
    Ahn, Jae Sook
    Yang, Duk-Hwan
    Kim, Yeo-Kyeoung
    Lee, Je-Jung
    Kim, Hyeoung-Joon
    Chung, Ik-Joo
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2008, 23 (04) : 586 - 591
  • [50] Combination chemotherapy with docetaxel, cisplatin, and 5-fluorouracil in previously treated patients with advanced/recurrent head and neck cancer - A phase II feasibility study
    Janinis, J
    Papadakou, M
    Xidakis, E
    Boukis, H
    Poulis, A
    Panagos, G
    Lefantzis, D
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2000, 23 (02): : 128 - 131
12345